ZimVie (NASDAQ:ZIMV – Get Free Report) will release its earnings data after the market closes on Wednesday, May 8th. ZimVie has set its FY 2024 guidance at EPS and its Q1 2024 guidance at EPS.Parties interested in listening to the company’s conference call can do so using this link.
ZimVie (NASDAQ:ZIMV – Get Free Report) last announced its quarterly earnings results on Wednesday, February 28th. The company reported $0.10 EPS for the quarter. The company had revenue of $113.07 million during the quarter. ZimVie had a positive return on equity of 2.44% and a negative net margin of 51.33%.
ZimVie Price Performance
Shares of NASDAQ:ZIMV opened at $15.20 on Wednesday. The company has a debt-to-equity ratio of 1.26, a quick ratio of 2.32 and a current ratio of 2.78. The business has a 50-day moving average of $16.93 and a two-hundred day moving average of $14.67. ZimVie has a 12 month low of $6.52 and a 12 month high of $20.91.
Wall Street Analyst Weigh In
View Our Latest Report on ZIMV
ZimVie Company Profile
ZimVie Inc, together with its subsidiaries, develops, manufactures, and markets a portfolio of products and solutions designed to treat various spine pathologies, and support dental tooth replacement and restoration procedures worldwide. It operates through two segments, The Dental Segment and The Spine Segment.
See Also
- Five stocks we like better than ZimVie
- How to Invest in the Best Canadian Stocks
- Goldman Boosted FMC Stock’s Price Targets, Setting Up a Breakout
- Using the MarketBeat Dividend Yield Calculator
- Impinj Proves The Internet-of-Things (IoT) is No Fluke
- The Significance of a Trillion-Dollar Market Cap Goes Beyond a Number
- PayPal’s Strong Earnings Growth and Strategic Evolution
Receive News & Ratings for ZimVie Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for ZimVie and related companies with MarketBeat.com's FREE daily email newsletter.